finance-abhi

Blue Jet Healthcare IPO

Blue Jet Healthcare is a 1968-founded specialty pharmaceutical, healthcare ingredient, and intermediate business. On the strength of strategic and early investments in research and development (R&D) and manufacturing infrastructure, it has established a contract development and manufacturing organisation (CDMO) business model with specialised chemistry capabilities in contrast to media intermediates and high-intensity sweeteners.

By June 30, 2023, the business had served over 400 clients in 39 nations. The main divisions of Blue Jet Healthcare’s business are three product categories:

Intermediates in Contrast Media

High-intensity Sweeteners Pharma Intermediates, Active Pharmaceutical Ingredients (APIs), and Pharma Intermediates: As of June 30, 2023, Blue Jet operated three manufacturing facilities in the Indian state of Maharashtra, located in Shahad, Ambernath, and Mahad. These facilities had an annual installed capacity of 200.60 KL, 607.30 KL, and 213.00 KL, respectively.

Blue Jet Healthcare IPO Details

Signature Global IPO Details
Blue Jet Healthcare IPO Dates
25 – 27 October 2023
Blue Jet Healthcare IPO Price
INR 329 – 346 per share
Fresh issue
Nil
Offer For Sale
24,285,160 shares (INR 798.98 – 840.27 crore)
Total IPO Size
24,285,160 shares (INR 798.98 – 840.27 crore)
Minimum bid (size)
43 shares (INR 14,878)
Face Value
INR 2 per share
Retail Allocation
35%
Listing On
BSE, NSE

Blue Jet Healthcare Financial Performance

Signature Global Financial Performance

FY21

FY22*

FY23*

Q1 FY 23*

Revenue

498.93

683.47

720.98

179.54

Expenses

317.85

459.65

528.33

126.68

Net income

135.78

181.72

159.94

44.19

Margin (%)

27.21

26.59

22.18

24.61

Figures in INR Crore unless specified otherwise

finance-abhi

Get the latest IPO and finance  news and stay informed about market trends and investment opportunities with Finance Abhi.

Follow Us